EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

ATP1A2 ‐related epileptic encephalopathy and movement disorder: Clinical features of three novel patients

Natalia Martínez Córdoba iD, Isabella Lince-Rivera iD, Jorge Luis Ramón Gómez iD, Guido Rubboli iD, Sebastián Ortiz De la Rosa iD

Epileptic Disorders · 2024

DOI: 10.1002/epd2.20220 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Epileptic Disorders, 2024. Verfasst von Natalia Martínez Córdoba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Militar Nueva Granada, Bogotá, Colombia. Hauptthemen laut MEDLINE: Sodium-Potassium-Exchanging ATPase, Movement Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Variants in the ATP1A2 gene exhibit a wide clinical spectrum, ranging from familial hemiplegic migraine to childhood epilepsies and early infantile developmental epileptic encephalopathy (EIDEE) with movement disorders. This study aims to describe the epileptology of three unpublished cases and summarize epilepsy features of the other 17 published cases with ATP1A2 variants and EIDEE.

Methods

Medical records of three novel patients with pathogenic ATP1A2 variants were retrospectively reviewed. Additionally, the PUBMED, EMBASE, and Cochrane databases were searched until December 2023 for articles on EIDEE with ATP1A2 variants, without language or publication year restrictions.

Results

Three female patients, aged 6 months–10 years, were investigated. Epilepsy onset occurred between 5 days and 2 years, accompanied by severe developmental delay, intellectual disability, drug‐resistant epilepsy, severe movement disorder, and recurrent status epilepticus. All individuals had pathogenic variants of the ATP1A2 gene ( ATP1A2 c.720_721del (p.Ile240MetfsTer9), ATP1A2c.3022C > T (p.Arg1008Trp) , ATP1A2 c.1096G > T (p.Gly366Cys) , according to ACMG criteria. Memantine was p) rescribed to three patients, one with a reduction in ictal frequency, one with improvement in gait pattern, coordination, and attention span, and another one in alertness without significant side effects. Significance This study reinforces the association between ATP1A2 variants and a severe phenotype. All patients had de novo variants, focal motor seizures with impaired awareness as the primary type of seizure; of the 11 EEGs recorded, 10 presented a slow background rhythm, 7 multifocal interictal epileptiform discharges (IED), predominantly temporal IEDs, followed by frontal IED, as well as ten ictal recordings, which showed ictal onset from the same regions mentioned above. Treatment with antiseizure medication was generally ineffective, but memantine showed moderate improvement. Prospective studies are needed to enlarge the phenotype and assess the efficacy of NMDA receptor antagonist therapies in reducing seizure frequency and improving quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Potassium-Exchanging ATPaseMovement DisordersHumansFemaleInfantChildSpasms, InfantileChild, PreschoolDrug Resistant EpilepsyIntellectual DisabilityRetrospective StudiesMemantine

Stichwörter der Autor:innen

ATP1A2NMDA receptor antagonistsdrug‐resistant epilepsyencephalopathiesgenetic epilepsy

Substanzen

Sodium-Potassium-Exchanging ATPaseATP1A2 protein, humanMemantine

Autor:innen und Institutionen

  • Universidad Militar Nueva Granada, Bogotá, Colombia.
  • Movement Disorders Specialist, Instituto Roosevelt, Bogotá, Colombia.
  • Danish Epilepsy Center, Member of ERN EpiCARE, Dianalund, Denmark.
  • Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Instituto Roosevelt, Bogotá, Colombia.
  • Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund, Denmark.

ORCID-Profile: Natalia Martínez Córdoba, Isabella Lince-Rivera, Jorge Luis Ramón Gómez, Guido Rubboli, Sebastián Ortiz De la Rosa

Zitieren

APA

Córdoba, N. M., Lince-Rivera, I., Gómez, J. L. R., Rubboli, G., & De la Rosa, S. O. (2024). ATP1A2 ‐related epileptic encephalopathy and movement disorder: Clinical features of three novel patients. Epileptic Disorders. https://doi.org/10.1002/epd2.20220

Vancouver

Córdoba NM, Lince-Rivera I, Gómez JLR, Rubboli G, De la Rosa SO. ATP1A2 ‐related epileptic encephalopathy and movement disorder: Clinical features of three novel patients. Epileptic Disorders. 2024. doi:10.1002/epd2.20220

BibTeX
@article{Crdoba2024,
  author = {Córdoba, Natalia Martínez and Lince-Rivera, Isabella and Gómez, Jorge Luis Ramón and Rubboli, Guido and De la Rosa, Sebastián Ortiz},
  title = {ATP1A2 ‐related epileptic encephalopathy and movement disorder: Clinical features of three novel patients},
  journal = {Epileptic Disorders},
  year = {2024},
  doi = {10.1002/epd2.20220}
}
Kostenlos starten →